CONFLICT OF INTEREST STATEMENT EMB reports personal fees and nonfinancial support from Grifols, Abbott, UpToDate, Tegus, and Health Advances outside of the submitted work. EMB is a co-investigator on a US government funded clinical trial evaluating Mirasol Pathogen Reduction Technology. REFERENCES 1, , , , , , et al. Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages. Transfusion. 2022; 62: 173–182. https://doi.org/10.1111/trf.16723 2, , , , .